Gremlin-1 associates with fibrillin microfibrils in vivo and regulates mesothelioma cell survival through transcription factor slug
Malignant mesothelioma is a form of cancer that is highly resistant to conventional cancer therapy for which no major therapeutic advances have been introduced. Here, we identify gremlin-1, a known bone morphogenetic protein inhibitor crucial for embryonic development, as a potential therapeutic tar...
Saved in:
Published in | Oncogenesis (New York, NY) Vol. 2; no. 8; p. e66 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.08.2013
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Malignant mesothelioma is a form of cancer that is highly resistant to conventional cancer therapy for which no major therapeutic advances have been introduced. Here, we identify gremlin-1, a known bone morphogenetic protein inhibitor crucial for embryonic development, as a potential therapeutic target for mesothelioma. We found high expression levels of gremlin-1 in the mesothelioma tumor tissue, as well as in primary mesothelioma cells cultured from pleural effusion samples. Downregulation of gremlin-1 expression by siRNA-mediated silencing in a mesothelioma cell line inhibited cell proliferation. This was associated with downregulation of the transcription factor slug as well as mesenchymal proteins linked to cancer epithelial-to-mesenchymal transition. Further, resistance to paclitaxel-induced cell death was associated with high gremlin-1 and slug expression. Treatment of gremlin-1-silenced mesothelioma cells with paclitaxel or pemetrexed resulted in efficient loss of cell survival. Finally, our data suggest that concomitant upregulation of fibrillin-2 in mesothelioma provides a mechanism for extracellular localization of gremlin-1 to the tumor microenvironment. This was supported by the demonstration of interactions between gremlin-1, and fibrillin-1 and -2 peptides as well as by colocalization of gremlin-1 to fibrillin microfibrils in cells and tumor tissue samples. Our data suggest that gremlin-1 is also a potential target for overcoming drug resistance in mesothelioma. |
---|---|
AbstractList | Malignant mesothelioma is a form of cancer that is highly resistant to conventional cancer therapy for which no major therapeutic advances have been introduced. Here, we identify gremlin-1, a known bone morphogenetic protein inhibitor crucial for embryonic development, as a potential therapeutic target for mesothelioma. We found high expression levels of gremlin-1 in the mesothelioma tumor tissue, as well as in primary mesothelioma cells cultured from pleural effusion samples. Downregulation of gremlin-1 expression by siRNA-mediated silencing in a mesothelioma cell line inhibited cell proliferation. This was associated with downregulation of the transcription factor slug as well as mesenchymal proteins linked to cancer epithelial-to-mesenchymal transition. Further, resistance to paclitaxel-induced cell death was associated with high gremlin-1 and slug expression. Treatment of gremlin-1-silenced mesothelioma cells with paclitaxel or pemetrexed resulted in efficient loss of cell survival. Finally, our data suggest that concomitant upregulation of fibrillin-2 in mesothelioma provides a mechanism for extracellular localization of gremlin-1 to the tumor microenvironment. This was supported by the demonstration of interactions between gremlin-1, and fibrillin-1 and -2 peptides as well as by colocalization of gremlin-1 to fibrillin microfibrils in cells and tumor tissue samples. Our data suggest that gremlin-1 is also a potential target for overcoming drug resistance in mesothelioma. |
Author | Myllärniemi, M Murray, L Varjosalo, M Rönty, M Koli, K Renkonen, R Tamminen, J A Wohl, A P Ritvos, O Sengle, G Parviainen, V Joenväärä, S Leppäranta, O |
Author_xml | – sequence: 1 givenname: J A surname: Tamminen fullname: Tamminen, J A organization: Research Programs Unit, Translational Cancer Biology, University of Helsinki, Transplantation Laboratory, Haartman Institute, University of Helsinki – sequence: 2 givenname: V surname: Parviainen fullname: Parviainen, V organization: Transplantation Laboratory, Haartman Institute, University of Helsinki – sequence: 3 givenname: M surname: Rönty fullname: Rönty, M organization: Helsinki University Central Hospital and Hospital Laboratory, Department of Pathology, University of Helsinki – sequence: 4 givenname: A P surname: Wohl fullname: Wohl, A P organization: Center for Biochemistry, Medical Faculty, University of Cologne – sequence: 5 givenname: L surname: Murray fullname: Murray, L organization: Research Programs Unit, Translational Cancer Biology, University of Helsinki, Transplantation Laboratory, Haartman Institute, University of Helsinki – sequence: 6 givenname: S surname: Joenväärä fullname: Joenväärä, S organization: Transplantation Laboratory, Haartman Institute, University of Helsinki – sequence: 7 givenname: M surname: Varjosalo fullname: Varjosalo, M organization: Institute of Biotechnology, University of Helsinki – sequence: 8 givenname: O surname: Leppäranta fullname: Leppäranta, O organization: Division of Pulmonary Medicine, Department of Medicine, University of Helsinki – sequence: 9 givenname: O surname: Ritvos fullname: Ritvos, O organization: Helsinki University Central Hospital and Hospital Laboratory, Department of Bacteriology and Immunology, University of Helsinki – sequence: 10 givenname: G surname: Sengle fullname: Sengle, G organization: Center for Biochemistry, Medical Faculty, University of Cologne – sequence: 11 givenname: R surname: Renkonen fullname: Renkonen, R organization: Transplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki University Central Hospital and Hospital Laboratory – sequence: 12 givenname: M surname: Myllärniemi fullname: Myllärniemi, M organization: Division of Pulmonary Medicine, Department of Medicine, University of Helsinki – sequence: 13 givenname: K surname: Koli fullname: Koli, K email: katri.koli@helsinki.fi organization: Research Programs Unit, Translational Cancer Biology, University of Helsinki, Transplantation Laboratory, Haartman Institute, University of Helsinki |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23978876$$D View this record in MEDLINE/PubMed |
BookMark | eNptkU1r3DAQhkVJSNIk1x6LoJdevNGHZVuXQgltWgj0kruQtbKtIEtbjbyl5_7xauskbEuFQBrmmVczel-jkxCDRegNJRtKeHcTgwEHG0Yo3zD5Cl0wKtpKElafHN3P0TXAIylLNLQR4gydMy7brmubC_TrLtnZu1BRrAGicTpbwD9cnvDg-uR8yeHZmRTXEHCJ924fsQ5bnOy4-D8Vs4WYJ-tdnDU21nsMSyqc9jhPKS7jhHPSAUxyu-xiwIM2OSYMfhmv0OmgPdjrp_MSPXz-9HD7pbr_dvf19uN9ZWpJc9X3AxHUym5gjbC95rwnUm5rXpO6NdLKvuNSE0N1qztpyVCXXRNNOGkIo_wSfVhld0s_262xoXTk1S65WaefKmqn_s4EN6kx7hVvhaSsKwLvnwRS_L5YyGp2cJhVBxsXULSVRDbFGVbQd_-gj3FJoUxXqK7jQlBx6GizUuV7AZIdXpqhRB0cVqvD6uCwYrIUvD0e4QV_9rMANysAJRVGm47e_b_kb0hPuCs |
CitedBy_id | crossref_primary_10_1042_BSR20200164 crossref_primary_10_1155_2014_802841 crossref_primary_10_2139_ssrn_4128861 crossref_primary_10_1016_j_semcdb_2018_07_016 crossref_primary_10_1074_jbc_AC119_010148 crossref_primary_10_18632_oncotarget_8434 crossref_primary_10_3390_biomedicines10020301 crossref_primary_10_1038_s41416_020_0945_0 crossref_primary_10_1016_j_matbio_2015_05_002 crossref_primary_10_1371_journal_pone_0159010 crossref_primary_10_3390_ijms21113888 crossref_primary_10_18632_oncotarget_3118 crossref_primary_10_3390_ijms21176342 crossref_primary_10_1038_s41388_018_0153_z crossref_primary_10_15616_BSL_2018_24_4_285 crossref_primary_10_3389_fphar_2019_00532 crossref_primary_10_1016_j_tcb_2014_12_004 crossref_primary_10_1016_j_bbrc_2020_10_025 crossref_primary_10_1002_pro_2485 crossref_primary_10_1016_j_yexcr_2014_12_010 crossref_primary_10_1007_s00018_021_03964_x crossref_primary_10_18632_oncotarget_21550 crossref_primary_10_3390_cancers12082149 crossref_primary_10_1016_j_yexcr_2020_111941 crossref_primary_10_3389_fonc_2022_968610 crossref_primary_10_1074_jbc_M114_628412 crossref_primary_10_1038_s41598_018_28297_x crossref_primary_10_1152_ajprenal_00344_2016 crossref_primary_10_1186_s12935_019_0852_8 crossref_primary_10_1016_j_mbplus_2021_100071 crossref_primary_10_1007_s13277_015_4093_8 |
Cites_doi | 10.1111/j.1600-0463.2012.02931.x 10.1016/j.cell.2009.11.007 10.1073/pnas.0606857103 10.1038/onc.2008.232 10.1167/iovs.07-0086 10.1242/dev.01251 10.3816/CLC.2009.n.014 10.1074/jbc.M406696200 10.1016/j.yexcr.2011.04.006 10.1093/carcin/bgn274 10.1093/carcin/bgr110 10.1016/j.bone.2008.06.016 10.1007/978-1-60761-842-3_11 10.1371/journal.pone.0042264 10.1074/jbc.M210611200 10.1164/rccm.200706-945OC 10.1128/MCB.17.8.4801 10.1371/journal.pone.0035100 10.1073/pnas.0707210104 10.1016/j.ceb.2009.05.005 10.1183/09031936.00077309 10.1126/science.2153315 10.1038/nmeth.2400 10.1182/blood-2010-06-291930 10.2353/ajpath.2006.051263 10.1038/msb.2008.75 10.1007/s00441-012-1385-9 10.1186/gb-2008-9-9-r139 10.1038/modpathol.2011.144 10.1002/jcb.24094 10.1016/S0070-2153(06)75001-3 10.1016/S0006-291X(02)00828-8 10.1007/s00441-009-0822-x 10.1038/nrc2620 10.1074/jbc.M707820200 10.1016/j.ctrv.2012.03.001 10.1016/j.transproceed.2008.02.064 10.1038/labinvest.2010.49 10.1152/ajpendo.00389.2012 10.1016/S1097-2765(00)80067-2 10.1016/j.cell.2008.03.027 10.1007/s10911-010-9178-9 10.1186/1471-2407-6-74 10.1186/1471-2407-12-91 10.1016/j.yexcr.2005.08.008 10.1016/j.cellsig.2011.08.010 10.1074/jbc.275.12.8785 10.1002/ajim.20282 10.1016/j.stem.2007.11.009 |
ContentType | Journal Article |
Copyright | The Author(s) 2013 Copyright Nature Publishing Group Aug 2013 Copyright © 2013 Macmillan Publishers Limited 2013 Macmillan Publishers Limited |
Copyright_xml | – notice: The Author(s) 2013 – notice: Copyright Nature Publishing Group Aug 2013 – notice: Copyright © 2013 Macmillan Publishers Limited 2013 Macmillan Publishers Limited |
DBID | C6C NPM AAYXX CITATION 3V. 7X7 7XB 88A 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M2P M7P PIMPY PQEST PQQKQ PQUKI PRINS Q9U 7TO H94 5PM |
DOI | 10.1038/oncsis.2013.29 |
DatabaseName | Springer_OA刊 PubMed CrossRef ProQuest Central (Corporate) PHMC-Proquest健康医学期刊库 ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) Science Database Biological Science Database Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic Oncogenes and Growth Factors Abstracts AIDS and Cancer Research Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef Publicly Available Content Database ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) Oncogenes and Growth Factors Abstracts AIDS and Cancer Research Abstracts |
DatabaseTitleList | Oncogenes and Growth Factors Abstracts Publicly Available Content Database PubMed |
Database_xml | – sequence: 1 dbid: C6C name: Springer_OA刊 url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Gremlin in mesothelioma cell survival |
EISSN | 2157-9024 |
EndPage | e66 |
ExternalDocumentID | 4053348331 10_1038_oncsis_2013_29 23978876 |
Genre | Journal Article |
GroupedDBID | 0R~ 3V. 53G 5VS 7X7 88A 88I 8FE 8FH 8FI 8FJ AAJSJ ABDBF ABUWG ACGFS ACSMW ADBBV ADRAZ AENEX AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBLON EBS EJD FYUFA GNUQQ GROUPED_DOAJ HCIFZ HMCUK HYE IPNFZ KQ8 LK8 M0L M2P M48 M7P M~E NAO OK1 PGMZT PIMPY PQQKQ PROAC RIG RNT RNTTT RPM SNYQT UKHRP NPM AAYXX CITATION 7XB 8FK K9. PQEST PQUKI PRINS Q9U 7TO H94 5PM |
ID | FETCH-LOGICAL-c491t-bbf051e98f265eba33b099d434047c9e9b839a0c1a7a89e0f40f440a03060213 |
IEDL.DBID | RPM |
ISSN | 2157-9024 |
IngestDate | Tue Sep 17 21:22:30 EDT 2024 Fri Oct 25 05:06:53 EDT 2024 Thu Oct 10 17:19:01 EDT 2024 Fri Aug 23 03:15:26 EDT 2024 Sat Sep 28 07:52:43 EDT 2024 Fri Oct 11 20:34:46 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | gremlin mesothelioma EMT fibrillin slug |
Language | English |
License | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c491t-bbf051e98f265eba33b099d434047c9e9b839a0c1a7a89e0f40f440a03060213 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759128/ |
PMID | 23978876 |
PQID | 1788355151 |
PQPubID | 2041913 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3759128 proquest_miscellaneous_1790961032 proquest_journals_1788355151 crossref_primary_10_1038_oncsis_2013_29 pubmed_primary_23978876 springer_journals_10_1038_oncsis_2013_29 |
PublicationCentury | 2000 |
PublicationDate | 2013-08-01 |
PublicationDateYYYYMMDD | 2013-08-01 |
PublicationDate_xml | – month: 08 year: 2013 text: 2013-08-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: United States – name: New York |
PublicationTitle | Oncogenesis (New York, NY) |
PublicationTitleAbbrev | Oncogenesis |
PublicationTitleAlternate | Oncogenesis |
PublicationYear | 2013 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Fassina, Cappellesso, Guzzardo, Dalla Via, Piccolo, Ventura (CR43) 2012; 25 Haslehurst, Koti, Dharsee, Nuin, Evans, Geraci (CR19) 2012; 12 Lee, O’Meara, O’Brien, Kane (CR41) 2007; 48 Shih, Yang (CR42) 2011; 32 Ramirez, Rifkin (CR27) 2009; 21 Merikallio, Pääkko, Salmenkivi, Kinnula, Harju, Soini (CR44) 2012; 121 Namkoong, Shin, Kim, Ha, Cho, Hur (CR12) 2006; 6 Leppäranta, Sens, Salmenkivi, Kinnula, Keski-Oja, Myllärniemi (CR24) 2012; 348 Ke, Reddel, Gerwin, Reddel, Somers, McMenamin (CR47) 1989; 134 Koli, Myllärniemi, Vuorinen, Salmenkivi, Ryynänen, Kinnula (CR16) 2006; 169 Kim, Yoon, Lee, Ha, Kim, Kim (CR33) 2012; 7 Ramirez, Sakai (CR15) 2010; 339 Lin, Tiedemann, Vollbrandt, Peters, Batge, Brinckmann (CR26) 2002; 277 Kilpinen, Autio, Ojala, Iljin, Bucher, Sara (CR37) 2008; 9 Koli, Ryynänen, Keski-Oja (CR48) 2008; 43 Michos, Panman, Vintersten, Beier, Zeller, Zuniga (CR10) 2004; 131 Mossman, Bignon, Corn, Seaton, Gee (CR1) 1990; 247 Polyak, Weinberg (CR21) 2009; 9 Myllärniemi, Lindholm, Ryynänen, Kliment, Salmenkivi, Keski-Oja (CR49) 2008; 177 Gordon, Kirkbride, How, Blobe (CR30) 2009; 30 Mulvihill, Kwon, Lee, Fang, Choi, Ray (CR34) 2012; 7 Mani, Guo, Liao, Eaton, Ayyanan, Zhou (CR20) 2008; 133 Pasello, Ceresoli, Favaretto (CR45) 2013; 39 Topol, Bardot, Zhang, Resau, Huillard, Marx (CR8) 2000; 275 Vancheri, Failla, Crimi, Raghu (CR25) 2010; 35 Tamminen, Myllärniemi, Hyytiäinen, Keski-Oja, Koli (CR53) 2012; 113 Fenyo, Eriksson, Beavis (CR51) 2010; 673 Vorobiof, Mafafo (CR4) 2009; 10 Huuskonen, Rantanen (CR3) 2006; 49 Carvajal, Droguett, Burgos, Aros, Ardiles, Flores (CR40) 2008; 40 Sneddon, Zhen, Montgomery, van de Rijn, Tward, West (CR13) 2006; 103 Sneddon, Werb (CR35) 2007; 1 Wang, Zhang, Wen, Zheng, Lazarovici, Jiang (CR39) 2012; 24 Dallas, Chen, Sivakumar (CR28) 2006; 75 Hsu, Economides, Wang, Eimon, Harland (CR7) 1998; 1 Mitola, Ravelli, Moroni, Salvi, Leali, Ballmer-Hofer (CR46) 2010; 116 Brinckmann, Hunzelmann, Kahle, Rohwedel, Kramer, Gibson (CR23) 2010; 90 Micalizzi, Farabaugh, Ford (CR6) 2010; 15 Varjosalo, Sacco, Stukalov, van Drogen, Planyavsky, Hauri (CR14) 2013; 10 Thiery, Acloque, Huang, Nieto (CR17) 2009; 139 Wang, Zhi, Zhang, Jiang, Liu, Han (CR22) 2012; 27 Koli, Hyytiäinen, Ryynänen, Keski-Oja (CR29) 2005; 310 Chen, Athanasiou, Gu, Blair (CR38) 2002; 295 Kang, Oh, Lee, Kang, Kim, Kim (CR31) 2011; 317 Sengle, Charbonneau, Ono, Sasaki, Alvarez, Keene (CR9) 2008; 283 Catalano, Rodilossi, Rippo, Caprari, Procopio (CR18) 2004; 279 Dormoy, Jacqmin, Lang, Massfelder (CR5) 2012; 32 Topol, Marx, Laugier, Bogdanova, Boubnov, Clausen (CR11) 1997; 17 Glatter, Wepf, Aebersold, Gstaiger (CR50) 2009; 5 Katsuno, Hanyu, Kanda, Ishikawa, Akiyama, Iwase (CR32) 2008; 27 Kosinski, Li, Chan, Zhang, Ho, Tsui (CR36) 2007; 104 Hulmi, Oliveira, Silvennoinen, Hoogaars, Ma, Pierre (CR52) 2013; 304 Lanphear, Buncher (CR2) 1992; 34 20490631 - J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):117-34 15201225 - Development. 2004 Jul;131(14):3401-10 2153315 - Science. 1990 Jan 19;247(4940):294-301 17724219 - Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4291-9 12399449 - J Biol Chem. 2002 Dec 27;277(52):50795-804 2541616 - Am J Pathol. 1989 May;134(5):979-91 18455002 - Transplant Proc. 2008 Apr;40(3):734-9 23030626 - APMIS. 2013 Jan;121(1):1-10 22870311 - PLoS One. 2012;7(8):e42264 20195245 - Lab Invest. 2010 May;90(5):739-52 22429801 - BMC Cancer. 2012 Mar 19;12 :91 9234736 - Mol Cell Biol. 1997 Aug;17(8):4801-10 19513754 - Cell Tissue Res. 2010 Jan;339(1):71-82 21570392 - Exp Cell Res. 2011 Jul 15;317(12):1746-62 21906675 - Cell Signal. 2012 Jan;24(1):17-24 22993298 - Anticancer Res. 2012 Sep;32(9):3609-17 22514712 - PLoS One. 2012;7(4):e35100 16157329 - Exp Cell Res. 2005 Nov 1;310(2):370-82 22573546 - J Cell Biochem. 2012 Jul;113(7):2234-47 18371402 - Cell Stem Cell. 2007 Dec 13;1(6):607-11 18672106 - Bone. 2008 Oct;43(4):679-88 19262571 - Nat Rev Cancer. 2009 Apr;9(4):265-73 19362954 - Clin Lung Cancer. 2009 Mar;10(2):112-7 16470550 - Am J Ind Med. 2006 Mar;49(3):215-20 22434388 - Cell Tissue Res. 2012 Jun;348(3):491-503 20660291 - Blood. 2010 Nov 4;116(18):3677-80 16816361 - Am J Pathol. 2006 Jul;169(1):61-71 18663362 - Oncogene. 2008 Oct 23;27(49):6322-33 21935575 - Oncol Rep. 2012 Jan;27(1):58-64 19525102 - Curr Opin Cell Biol. 2009 Oct;21(5):616-22 16984808 - Curr Top Dev Biol. 2006;75:1-24 19056927 - Carcinogenesis. 2009 Feb;30(2):238-48 20835799 - Methods Mol Biol. 2010;673:189-202 19156129 - Mol Syst Biol. 2009;5:237 19945376 - Cell. 2009 Nov 25;139(5):871-90 17003113 - Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14842-7 23455922 - Nat Methods. 2013 Apr;10(4):307-14 10722723 - J Biol Chem. 2000 Mar 24;275(12):8785-93 12135612 - Biochem Biophys Res Commun. 2002 Aug 2;295(5):1135-41 18485877 - Cell. 2008 May 16;133(4):704-15 18339631 - J Biol Chem. 2008 May 16;283(20):13874-88 17975199 - Am J Respir Crit Care Med. 2008 Feb 1;177(3):321-9 18803840 - Genome Biol. 2008;9(9):R139 1494965 - J Occup Med. 1992 Jul;34(7):718-21 15337769 - J Biol Chem. 2004 Nov 5;279(45):46706-14 23115080 - Am J Physiol Endocrinol Metab. 2013 Jan 1;304(1):E41-50 21983934 - Mod Pathol. 2012 Jan;25(1):86-99 17881565 - Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15418-23 22459200 - Cancer Treat Rev. 2013 Feb;39(1):10-7 20190329 - Eur Respir J. 2010 Mar;35(3):496-504 21665887 - Carcinogenesis. 2011 Sep;32(9):1299-304 16545136 - BMC Cancer. 2006 Mar 18;6:74 9660951 - Mol Cell. 1998 Apr;1(5):673-83 F Ramirez (BFoncsis201329_CR27) 2009; 21 JJ Hulmi (BFoncsis201329_CR52) 2013; 304 H Lee (BFoncsis201329_CR41) 2007; 48 F Ramirez (BFoncsis201329_CR15) 2010; 339 J Brinckmann (BFoncsis201329_CR23) 2010; 90 K Koli (BFoncsis201329_CR16) 2006; 169 C Kosinski (BFoncsis201329_CR36) 2007; 104 D Fenyo (BFoncsis201329_CR51) 2010; 673 K Koli (BFoncsis201329_CR29) 2005; 310 Y Ke (BFoncsis201329_CR47) 1989; 134 O Leppäranta (BFoncsis201329_CR24) 2012; 348 A Fassina (BFoncsis201329_CR43) 2012; 25 KJ Gordon (BFoncsis201329_CR30) 2009; 30 G Sengle (BFoncsis201329_CR9) 2008; 283 LZ Topol (BFoncsis201329_CR11) 1997; 17 B Chen (BFoncsis201329_CR38) 2002; 295 S Mitola (BFoncsis201329_CR46) 2010; 116 BP Lanphear (BFoncsis201329_CR2) 1992; 34 G Lin (BFoncsis201329_CR26) 2002; 277 K Koli (BFoncsis201329_CR48) 2008; 43 BT Mossman (BFoncsis201329_CR1) 1990; 247 MH Kang (BFoncsis201329_CR31) 2011; 317 DR Hsu (BFoncsis201329_CR7) 1998; 1 V Dormoy (BFoncsis201329_CR5) 2012; 32 G Pasello (BFoncsis201329_CR45) 2013; 39 JY Shih (BFoncsis201329_CR42) 2011; 32 M Kim (BFoncsis201329_CR33) 2012; 7 H Namkoong (BFoncsis201329_CR12) 2006; 6 K Polyak (BFoncsis201329_CR21) 2009; 9 JB Sneddon (BFoncsis201329_CR35) 2007; 1 DS Micalizzi (BFoncsis201329_CR6) 2010; 15 DA Vorobiof (BFoncsis201329_CR4) 2009; 10 A Catalano (BFoncsis201329_CR18) 2004; 279 H Merikallio (BFoncsis201329_CR44) 2012; 121 M Varjosalo (BFoncsis201329_CR14) 2013; 10 AM Haslehurst (BFoncsis201329_CR19) 2012; 12 M Myllärniemi (BFoncsis201329_CR49) 2008; 177 T Glatter (BFoncsis201329_CR50) 2009; 5 DJ Wang (BFoncsis201329_CR22) 2012; 27 JP Thiery (BFoncsis201329_CR17) 2009; 139 MS Huuskonen (BFoncsis201329_CR3) 2006; 49 JA Tamminen (BFoncsis201329_CR53) 2012; 113 SL Dallas (BFoncsis201329_CR28) 2006; 75 S Kilpinen (BFoncsis201329_CR37) 2008; 9 H Wang (BFoncsis201329_CR39) 2012; 24 G Carvajal (BFoncsis201329_CR40) 2008; 40 Y Katsuno (BFoncsis201329_CR32) 2008; 27 SA Mani (BFoncsis201329_CR20) 2008; 133 O Michos (BFoncsis201329_CR10) 2004; 131 JB Sneddon (BFoncsis201329_CR13) 2006; 103 LZ Topol (BFoncsis201329_CR8) 2000; 275 MS Mulvihill (BFoncsis201329_CR34) 2012; 7 C Vancheri (BFoncsis201329_CR25) 2010; 35 |
References_xml | – volume: 121 start-page: 1 year: 2012 end-page: 10 ident: CR44 article-title: Expression of snail, twist, and Zeb1 in malignant mesothelioma publication-title: APMIS doi: 10.1111/j.1600-0463.2012.02931.x contributor: fullname: Soini – volume: 32 start-page: 3609 year: 2012 end-page: 3617 ident: CR5 article-title: From development to cancer: lessons from the kidney to uncover new therapeutic targets publication-title: Anticancer Res contributor: fullname: Massfelder – volume: 139 start-page: 871 year: 2009 end-page: 890 ident: CR17 article-title: Epithelial-mesenchymal transitions in development and disease publication-title: Cell doi: 10.1016/j.cell.2009.11.007 contributor: fullname: Nieto – volume: 103 start-page: 14842 year: 2006 end-page: 14847 ident: CR13 article-title: Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0606857103 contributor: fullname: West – volume: 27 start-page: 6322 year: 2008 end-page: 6333 ident: CR32 article-title: Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway publication-title: Oncogene doi: 10.1038/onc.2008.232 contributor: fullname: Iwase – volume: 134 start-page: 979 year: 1989 end-page: 991 ident: CR47 article-title: Establishment of a human mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma publication-title: Am J Pathol contributor: fullname: McMenamin – volume: 48 start-page: 4291 year: 2007 end-page: 4299 ident: CR41 article-title: The role of gremlin, a BMP antagonist, and epithelial-to-mesenchymal transition in proliferative vitreoretinopathy publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.07-0086 contributor: fullname: Kane – volume: 131 start-page: 3401 year: 2004 end-page: 3410 ident: CR10 article-title: antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis publication-title: Development doi: 10.1242/dev.01251 contributor: fullname: Zuniga – volume: 10 start-page: 112 year: 2009 end-page: 117 ident: CR4 article-title: Malignant pleural mesothelioma: medical treatment update publication-title: Clin Lung Cancer doi: 10.3816/CLC.2009.n.014 contributor: fullname: Mafafo – volume: 279 start-page: 46706 year: 2004 end-page: 46714 ident: CR18 article-title: Induction of stem cell factor/c-Kit/slug signal transduction in multidrug-resistant malignant mesothelioma cells publication-title: J Biol Chem doi: 10.1074/jbc.M406696200 contributor: fullname: Procopio – volume: 317 start-page: 1746 year: 2011 end-page: 1762 ident: CR31 article-title: Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2011.04.006 contributor: fullname: Kim – volume: 30 start-page: 238 year: 2009 end-page: 248 ident: CR30 article-title: Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2 publication-title: Carcinogenesis doi: 10.1093/carcin/bgn274 contributor: fullname: Blobe – volume: 32 start-page: 1299 year: 2011 end-page: 1304 ident: CR42 article-title: The EMT regulator slug and lung carcinogenesis publication-title: Carcinogenesis doi: 10.1093/carcin/bgr110 contributor: fullname: Yang – volume: 43 start-page: 679 year: 2008 end-page: 688 ident: CR48 article-title: Latent TGF-β binding proteins (LTBPs)-1 and -3 coordinate proliferation and osteogenic differentiation of human mesenchymal stem cells publication-title: Bone doi: 10.1016/j.bone.2008.06.016 contributor: fullname: Keski-Oja – volume: 673 start-page: 189 year: 2010 end-page: 202 ident: CR51 article-title: Mass spectrometric protein identification using the global proteome machine publication-title: Methods Mol Biol doi: 10.1007/978-1-60761-842-3_11 contributor: fullname: Beavis – volume: 7 start-page: e42264 year: 2012 ident: CR34 article-title: Gremlin is overexpressed in lung adenocarcinoma and increases cell growth and proliferation in normal lung cells publication-title: PLoS One doi: 10.1371/journal.pone.0042264 contributor: fullname: Ray – volume: 277 start-page: 50795 year: 2002 end-page: 50804 ident: CR26 article-title: Homo- and heterotypic fibrillin-1 and -2 interactions constitute the basis for the assembly of microfibrils publication-title: J Biol Chem doi: 10.1074/jbc.M210611200 contributor: fullname: Brinckmann – volume: 177 start-page: 321 year: 2008 end-page: 329 ident: CR49 article-title: Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200706-945OC contributor: fullname: Keski-Oja – volume: 17 start-page: 4801 year: 1997 end-page: 4810 ident: CR11 article-title: Identification of drm, a novel gene whose expression is suppressed in transformed cells and which can inhibit growth of normal but not transformed cells in culture publication-title: Mol Cell Biol doi: 10.1128/MCB.17.8.4801 contributor: fullname: Clausen – volume: 7 start-page: e35100 year: 2012 ident: CR33 article-title: Gremlin-1 induces BMP-independent tumor cell proliferation, migration, and invasion publication-title: PLoS One doi: 10.1371/journal.pone.0035100 contributor: fullname: Kim – volume: 104 start-page: 15418 year: 2007 end-page: 15423 ident: CR36 article-title: Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0707210104 contributor: fullname: Tsui – volume: 21 start-page: 616 year: 2009 end-page: 622 ident: CR27 article-title: Extracellular microfibrils: contextual platforms for TGFβ and BMP signaling publication-title: Curr Opin Cell Biol doi: 10.1016/j.ceb.2009.05.005 contributor: fullname: Rifkin – volume: 35 start-page: 496 year: 2010 end-page: 504 ident: CR25 article-title: Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology publication-title: Eur Respir J doi: 10.1183/09031936.00077309 contributor: fullname: Raghu – volume: 247 start-page: 294 year: 1990 end-page: 301 ident: CR1 article-title: Asbestos: scientific developments and implications for public policy publication-title: Science doi: 10.1126/science.2153315 contributor: fullname: Gee – volume: 10 start-page: 307 year: 2013 end-page: 314 ident: CR14 article-title: Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS publication-title: Nat Methods doi: 10.1038/nmeth.2400 contributor: fullname: Hauri – volume: 116 start-page: 3677 year: 2010 end-page: 3680 ident: CR46 article-title: Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2 publication-title: Blood doi: 10.1182/blood-2010-06-291930 contributor: fullname: Ballmer-Hofer – volume: 27 start-page: 58 year: 2012 end-page: 64 ident: CR22 article-title: The bone morphogenetic protein antagonist Gremlin is overexpressed in human malignant mesothelioma publication-title: Oncol Rep contributor: fullname: Han – volume: 169 start-page: 61 year: 2006 end-page: 71 ident: CR16 article-title: Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis publication-title: Am J Pathol doi: 10.2353/ajpath.2006.051263 contributor: fullname: Kinnula – volume: 5 start-page: 237 year: 2009 ident: CR50 article-title: An integrated workflow for charting the human interaction proteome: insights into the PP2A system publication-title: Mol Syst Biol doi: 10.1038/msb.2008.75 contributor: fullname: Gstaiger – volume: 348 start-page: 491 year: 2012 end-page: 503 ident: CR24 article-title: Regulation of TGF-β storage and activation in the human idiopathic pulmonary fibrosis lung publication-title: Cell Tissue Res doi: 10.1007/s00441-012-1385-9 contributor: fullname: Myllärniemi – volume: 9 start-page: R139 year: 2008 ident: CR37 article-title: Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues publication-title: Genome Biol doi: 10.1186/gb-2008-9-9-r139 contributor: fullname: Sara – volume: 25 start-page: 86 year: 2012 end-page: 99 ident: CR43 article-title: Epithelial-mesenchymal transition in malignant mesothelioma publication-title: Mod Pathol doi: 10.1038/modpathol.2011.144 contributor: fullname: Ventura – volume: 113 start-page: 2234 year: 2012 end-page: 2247 ident: CR53 article-title: Asbestos exposure induces alveolar epithelial cell plasticity through MAPK/Erk signaling publication-title: J Cell Biochem doi: 10.1002/jcb.24094 contributor: fullname: Koli – volume: 75 start-page: 1 year: 2006 end-page: 24 ident: CR28 article-title: Dynamics of assembly and reorganization of extracellular matrix proteins publication-title: Curr Top Dev Biol doi: 10.1016/S0070-2153(06)75001-3 contributor: fullname: Sivakumar – volume: 295 start-page: 1135 year: 2002 end-page: 1141 ident: CR38 article-title: Drm/Gremlin transcriptionally activates p21(Cip1) via a novel mechanism and inhibits neoplastic transformation publication-title: Biochem Biophys Res Commun doi: 10.1016/S0006-291X(02)00828-8 contributor: fullname: Blair – volume: 339 start-page: 71 year: 2010 end-page: 82 ident: CR15 article-title: Biogenesis and function of fibrillin assemblies publication-title: Cell Tissue Res doi: 10.1007/s00441-009-0822-x contributor: fullname: Sakai – volume: 9 start-page: 265 year: 2009 end-page: 273 ident: CR21 article-title: Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits publication-title: Nat Rev Cancer doi: 10.1038/nrc2620 contributor: fullname: Weinberg – volume: 283 start-page: 13874 year: 2008 end-page: 13888 ident: CR9 article-title: Targeting of bone morphogenetic protein growth factor complexes to fibrillin publication-title: J Biol Chem doi: 10.1074/jbc.M707820200 contributor: fullname: Keene – volume: 39 start-page: 10 year: 2013 end-page: 17 ident: CR45 article-title: An overview of neoadjuvant chemotherapy in the multimodality treatment of malignant pleural mesothelioma publication-title: Cancer Treat Rev doi: 10.1016/j.ctrv.2012.03.001 contributor: fullname: Favaretto – volume: 40 start-page: 734 year: 2008 end-page: 739 ident: CR40 article-title: Gremlin: a novel mediator of epithelial mesenchymal transition and fibrosis in chronic allograft nephropathy publication-title: Transplant Proc doi: 10.1016/j.transproceed.2008.02.064 contributor: fullname: Flores – volume: 90 start-page: 739 year: 2010 end-page: 752 ident: CR23 article-title: Enhanced fibrillin-2 expression is a general feature of wound healing and sclerosis: potential alteration of cell attachment and storage of TGF-β publication-title: Lab Invest doi: 10.1038/labinvest.2010.49 contributor: fullname: Gibson – volume: 304 start-page: E41 year: 2013 end-page: E50 ident: CR52 article-title: Muscle protein synthesis, mTORC1/MAPK/Hippo signaling, and capillary density are altered by blocking of myostatin and activins publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00389.2012 contributor: fullname: Pierre – volume: 1 start-page: 673 year: 1998 end-page: 683 ident: CR7 article-title: The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities publication-title: Mol Cell doi: 10.1016/S1097-2765(00)80067-2 contributor: fullname: Harland – volume: 133 start-page: 704 year: 2008 end-page: 715 ident: CR20 article-title: The epithelial-mesenchymal transition generates cells with properties of stem cells publication-title: Cell doi: 10.1016/j.cell.2008.03.027 contributor: fullname: Zhou – volume: 15 start-page: 117 year: 2010 end-page: 134 ident: CR6 article-title: Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression publication-title: J Mammary Gland Biol Neoplasia doi: 10.1007/s10911-010-9178-9 contributor: fullname: Ford – volume: 6 start-page: 74 year: 2006 ident: CR12 article-title: The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein publication-title: BMC Cancer doi: 10.1186/1471-2407-6-74 contributor: fullname: Hur – volume: 12 start-page: 91 year: 2012 ident: CR19 article-title: EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer publication-title: BMC Cancer doi: 10.1186/1471-2407-12-91 contributor: fullname: Geraci – volume: 310 start-page: 370 year: 2005 end-page: 382 ident: CR29 article-title: Sequential deposition of latent TGF-β binding proteins (LTBPs) during formation of the extracellular matrix in human lung fibroblasts publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2005.08.008 contributor: fullname: Keski-Oja – volume: 24 start-page: 17 year: 2012 end-page: 24 ident: CR39 article-title: Proline-rich Akt substrate of 40kDa (PRAS40): a novel downstream target of PI3k/Akt signaling pathway publication-title: Cell Signal doi: 10.1016/j.cellsig.2011.08.010 contributor: fullname: Jiang – volume: 275 start-page: 8785 year: 2000 end-page: 8793 ident: CR8 article-title: Biosynthesis, post-translation modification, and functional characterization of Drm/Gremlin publication-title: J Biol Chem doi: 10.1074/jbc.275.12.8785 contributor: fullname: Marx – volume: 34 start-page: 718 year: 1992 end-page: 721 ident: CR2 article-title: Latent period for malignant mesothelioma of occupational origin publication-title: J Occup Med contributor: fullname: Buncher – volume: 49 start-page: 215 year: 2006 end-page: 220 ident: CR3 article-title: Finnish Institute of Occupational Health (FIOH): prevention and detection of asbestos-related diseases, 1987-2005 publication-title: Am J Ind Med doi: 10.1002/ajim.20282 contributor: fullname: Rantanen – volume: 1 start-page: 607 year: 2007 end-page: 611 ident: CR35 article-title: Location, location, location: the cancer stem cell niche publication-title: Cell Stem Cell doi: 10.1016/j.stem.2007.11.009 contributor: fullname: Werb – volume: 12 start-page: 91 year: 2012 ident: BFoncsis201329_CR19 publication-title: BMC Cancer doi: 10.1186/1471-2407-12-91 contributor: fullname: AM Haslehurst – volume: 40 start-page: 734 year: 2008 ident: BFoncsis201329_CR40 publication-title: Transplant Proc doi: 10.1016/j.transproceed.2008.02.064 contributor: fullname: G Carvajal – volume: 32 start-page: 3609 year: 2012 ident: BFoncsis201329_CR5 publication-title: Anticancer Res contributor: fullname: V Dormoy – volume: 17 start-page: 4801 year: 1997 ident: BFoncsis201329_CR11 publication-title: Mol Cell Biol doi: 10.1128/MCB.17.8.4801 contributor: fullname: LZ Topol – volume: 177 start-page: 321 year: 2008 ident: BFoncsis201329_CR49 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200706-945OC contributor: fullname: M Myllärniemi – volume: 25 start-page: 86 year: 2012 ident: BFoncsis201329_CR43 publication-title: Mod Pathol doi: 10.1038/modpathol.2011.144 contributor: fullname: A Fassina – volume: 304 start-page: E41 year: 2013 ident: BFoncsis201329_CR52 publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00389.2012 contributor: fullname: JJ Hulmi – volume: 247 start-page: 294 year: 1990 ident: BFoncsis201329_CR1 publication-title: Science doi: 10.1126/science.2153315 contributor: fullname: BT Mossman – volume: 5 start-page: 237 year: 2009 ident: BFoncsis201329_CR50 publication-title: Mol Syst Biol doi: 10.1038/msb.2008.75 contributor: fullname: T Glatter – volume: 9 start-page: R139 year: 2008 ident: BFoncsis201329_CR37 publication-title: Genome Biol doi: 10.1186/gb-2008-9-9-r139 contributor: fullname: S Kilpinen – volume: 24 start-page: 17 year: 2012 ident: BFoncsis201329_CR39 publication-title: Cell Signal doi: 10.1016/j.cellsig.2011.08.010 contributor: fullname: H Wang – volume: 310 start-page: 370 year: 2005 ident: BFoncsis201329_CR29 publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2005.08.008 contributor: fullname: K Koli – volume: 103 start-page: 14842 year: 2006 ident: BFoncsis201329_CR13 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0606857103 contributor: fullname: JB Sneddon – volume: 317 start-page: 1746 year: 2011 ident: BFoncsis201329_CR31 publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2011.04.006 contributor: fullname: MH Kang – volume: 9 start-page: 265 year: 2009 ident: BFoncsis201329_CR21 publication-title: Nat Rev Cancer doi: 10.1038/nrc2620 contributor: fullname: K Polyak – volume: 48 start-page: 4291 year: 2007 ident: BFoncsis201329_CR41 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.07-0086 contributor: fullname: H Lee – volume: 275 start-page: 8785 year: 2000 ident: BFoncsis201329_CR8 publication-title: J Biol Chem doi: 10.1074/jbc.275.12.8785 contributor: fullname: LZ Topol – volume: 35 start-page: 496 year: 2010 ident: BFoncsis201329_CR25 publication-title: Eur Respir J doi: 10.1183/09031936.00077309 contributor: fullname: C Vancheri – volume: 75 start-page: 1 year: 2006 ident: BFoncsis201329_CR28 publication-title: Curr Top Dev Biol doi: 10.1016/S0070-2153(06)75001-3 contributor: fullname: SL Dallas – volume: 1 start-page: 673 year: 1998 ident: BFoncsis201329_CR7 publication-title: Mol Cell doi: 10.1016/S1097-2765(00)80067-2 contributor: fullname: DR Hsu – volume: 49 start-page: 215 year: 2006 ident: BFoncsis201329_CR3 publication-title: Am J Ind Med doi: 10.1002/ajim.20282 contributor: fullname: MS Huuskonen – volume: 339 start-page: 71 year: 2010 ident: BFoncsis201329_CR15 publication-title: Cell Tissue Res doi: 10.1007/s00441-009-0822-x contributor: fullname: F Ramirez – volume: 10 start-page: 112 year: 2009 ident: BFoncsis201329_CR4 publication-title: Clin Lung Cancer doi: 10.3816/CLC.2009.n.014 contributor: fullname: DA Vorobiof – volume: 131 start-page: 3401 year: 2004 ident: BFoncsis201329_CR10 publication-title: Development doi: 10.1242/dev.01251 contributor: fullname: O Michos – volume: 1 start-page: 607 year: 2007 ident: BFoncsis201329_CR35 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2007.11.009 contributor: fullname: JB Sneddon – volume: 21 start-page: 616 year: 2009 ident: BFoncsis201329_CR27 publication-title: Curr Opin Cell Biol doi: 10.1016/j.ceb.2009.05.005 contributor: fullname: F Ramirez – volume: 277 start-page: 50795 year: 2002 ident: BFoncsis201329_CR26 publication-title: J Biol Chem doi: 10.1074/jbc.M210611200 contributor: fullname: G Lin – volume: 279 start-page: 46706 year: 2004 ident: BFoncsis201329_CR18 publication-title: J Biol Chem doi: 10.1074/jbc.M406696200 contributor: fullname: A Catalano – volume: 295 start-page: 1135 year: 2002 ident: BFoncsis201329_CR38 publication-title: Biochem Biophys Res Commun doi: 10.1016/S0006-291X(02)00828-8 contributor: fullname: B Chen – volume: 32 start-page: 1299 year: 2011 ident: BFoncsis201329_CR42 publication-title: Carcinogenesis doi: 10.1093/carcin/bgr110 contributor: fullname: JY Shih – volume: 15 start-page: 117 year: 2010 ident: BFoncsis201329_CR6 publication-title: J Mammary Gland Biol Neoplasia doi: 10.1007/s10911-010-9178-9 contributor: fullname: DS Micalizzi – volume: 43 start-page: 679 year: 2008 ident: BFoncsis201329_CR48 publication-title: Bone doi: 10.1016/j.bone.2008.06.016 contributor: fullname: K Koli – volume: 7 start-page: e35100 year: 2012 ident: BFoncsis201329_CR33 publication-title: PLoS One doi: 10.1371/journal.pone.0035100 contributor: fullname: M Kim – volume: 27 start-page: 6322 year: 2008 ident: BFoncsis201329_CR32 publication-title: Oncogene doi: 10.1038/onc.2008.232 contributor: fullname: Y Katsuno – volume: 348 start-page: 491 year: 2012 ident: BFoncsis201329_CR24 publication-title: Cell Tissue Res doi: 10.1007/s00441-012-1385-9 contributor: fullname: O Leppäranta – volume: 113 start-page: 2234 year: 2012 ident: BFoncsis201329_CR53 publication-title: J Cell Biochem doi: 10.1002/jcb.24094 contributor: fullname: JA Tamminen – volume: 90 start-page: 739 year: 2010 ident: BFoncsis201329_CR23 publication-title: Lab Invest doi: 10.1038/labinvest.2010.49 contributor: fullname: J Brinckmann – volume: 30 start-page: 238 year: 2009 ident: BFoncsis201329_CR30 publication-title: Carcinogenesis doi: 10.1093/carcin/bgn274 contributor: fullname: KJ Gordon – volume: 116 start-page: 3677 year: 2010 ident: BFoncsis201329_CR46 publication-title: Blood doi: 10.1182/blood-2010-06-291930 contributor: fullname: S Mitola – volume: 34 start-page: 718 year: 1992 ident: BFoncsis201329_CR2 publication-title: J Occup Med contributor: fullname: BP Lanphear – volume: 10 start-page: 307 year: 2013 ident: BFoncsis201329_CR14 publication-title: Nat Methods doi: 10.1038/nmeth.2400 contributor: fullname: M Varjosalo – volume: 39 start-page: 10 year: 2013 ident: BFoncsis201329_CR45 publication-title: Cancer Treat Rev doi: 10.1016/j.ctrv.2012.03.001 contributor: fullname: G Pasello – volume: 283 start-page: 13874 year: 2008 ident: BFoncsis201329_CR9 publication-title: J Biol Chem doi: 10.1074/jbc.M707820200 contributor: fullname: G Sengle – volume: 139 start-page: 871 year: 2009 ident: BFoncsis201329_CR17 publication-title: Cell doi: 10.1016/j.cell.2009.11.007 contributor: fullname: JP Thiery – volume: 27 start-page: 58 year: 2012 ident: BFoncsis201329_CR22 publication-title: Oncol Rep contributor: fullname: DJ Wang – volume: 104 start-page: 15418 year: 2007 ident: BFoncsis201329_CR36 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0707210104 contributor: fullname: C Kosinski – volume: 121 start-page: 1 year: 2012 ident: BFoncsis201329_CR44 publication-title: APMIS doi: 10.1111/j.1600-0463.2012.02931.x contributor: fullname: H Merikallio – volume: 673 start-page: 189 year: 2010 ident: BFoncsis201329_CR51 publication-title: Methods Mol Biol doi: 10.1007/978-1-60761-842-3_11 contributor: fullname: D Fenyo – volume: 169 start-page: 61 year: 2006 ident: BFoncsis201329_CR16 publication-title: Am J Pathol doi: 10.2353/ajpath.2006.051263 contributor: fullname: K Koli – volume: 133 start-page: 704 year: 2008 ident: BFoncsis201329_CR20 publication-title: Cell doi: 10.1016/j.cell.2008.03.027 contributor: fullname: SA Mani – volume: 6 start-page: 74 year: 2006 ident: BFoncsis201329_CR12 publication-title: BMC Cancer doi: 10.1186/1471-2407-6-74 contributor: fullname: H Namkoong – volume: 134 start-page: 979 year: 1989 ident: BFoncsis201329_CR47 publication-title: Am J Pathol contributor: fullname: Y Ke – volume: 7 start-page: e42264 year: 2012 ident: BFoncsis201329_CR34 publication-title: PLoS One doi: 10.1371/journal.pone.0042264 contributor: fullname: MS Mulvihill |
SSID | ssj0000561655 |
Score | 2.1449354 |
Snippet | Malignant mesothelioma is a form of cancer that is highly resistant to conventional cancer therapy for which no major therapeutic advances have been... |
SourceID | pubmedcentral proquest crossref pubmed springer |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | e66 |
SubjectTerms | 631/67/1059/602 631/67/1641 692/420/755 Apoptosis Cell Biology Human Genetics Internal Medicine Medicine Medicine & Public Health Oncology Original original-article |
SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS91AEB7qEcSXovXSVFtWEPRlNcluLvtUWlGkoEhR8C3sbjZ6wJNYc45_wD_uTLI59VIKeVmyIdmd2ZlvLpkB2BUuV1aaiDuhLUeNH3MllONCqCQxWlRlFzE9O09Pr-Sv6-TaO9xan1Y5yMROUJeNJR_5YYS2GupGVFDf7_9w6hpF0VXfQmMBFmO0FMIRLP48Pr_4PfeyED5Ok2So1ijyw6a27ZjqdEfioMOVL7TRO4j5PlPyTbi000InK_DRw0f2o6f3Knxw9SdYOvMB8jV4QpN_gsiRR0z7jXctI2crqyi5nypwswkl4fXDluH4cfzYMF2X7KFvTI9PTFxLv2bdjZuJZuTcZ-0MhQqyJfOdfdiUtNwgc1jft4e1d7Obdbg8Ob48OuW-zwK3UkVTbkyFR9OpvIrTxCGBhEHcWEohQ5lZ5ZRBFKVDG-lM58qFlcRLhprMDYQIYgNGdVO7z8Ay5UpZprZMcoPIxOTGGoRIkalygpYqgL1hu4v7vppG0UXBRV70hCmIMEWMM7cHahT-VLXFXx4IYGd-G88D7YOuXTOjOYq62IQiDmCzJ978VTGCLxSqaQDZK7LOJ1Ct7dd36vFtV3NbZIlCVR7A_sAALz7rnyv48v8VbMFy3HXWoFzCbRhNH2buK-KbqfnmmfgZ0RUAvA priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LT9wwEB4BlRAXBC0tAYqMVKlcTJPYefiAUIV4CAlOIHGL7MRpV9pN2s0ugjN_nJk42bJdDki5WHESxzP2fGOP5wP4JmyqcmkCboXOOVr8kCuhLBdCRZHRoizaHdPrm_jyTl7dR_f_4p-6DmzedO2IT-puPDx6_Pt0ggP-2B0ZT3_UVd4MKPV2II5CtQwfQoleOoXxdVDf5fmOg7glQUUjl3CFtqnP4bjwinkbtQA8F-Mn_9tEbW3T-Qasd6CS_XRasAlLtvoIq9fdtvkneL4Y2xHiSR4w3YnDNoyWYFlJIf-Ul5uNKDTPFRuG5YfBQ810VbCxo6vHJ0a2oQNbw0E90oyW_FkzxakGlZV1fD9sQravn4mYY_NhzXD6awtuz89uTy95x77Ac6mCCTemxAFrVVqGcWRRbMIgmiykkL5McmWVQWyl_TzQiU6V9UuJl_Q1OSEIHMRnWKnqym4DS5QtZBHnRZQaxCsmNblB4BSYMiXAqTz43nd39sfl2MjavXGRZk4wGQkmC7HmXi-NrFeVLEAvHlETQhcPDma3cZRQP-jK1lOqo4jbxhehB1-c8GafChGS4VQbe5DMiXVWgTJwz9-pBr_bTNwiiRQaeA8OewV41aw3_2DnHU3chbWwJd2gMMM9WJmMp_YrQp-J2W91-gXgBwa1 priority: 102 providerName: Scholars Portal – databaseName: Springer_OA刊 dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LS8QwEB58gHgR31ZXiSDopdo2aZscZVFE0NMKeytJm-rCbit21z_gH3emj8V1PQi9hExom5lkvslMZgAuuJUqFcZ3Ldepixo_cBVX1uVchaHRPM9qj-nTc_TwIh6H4bANkKW7MAv-ey5vyiKtRpRW2-fXgVqFddS_kkK3-lF_fpZCKDgKwy4n49KwRZ2zBCSX4yF_OUVrXXO_DVstSGS3DVd3YMUWu7Dx1LrB9-ALDfsJ4kPXZ7qdXlsxOlJlOYXwU55tNqFQu6ZZMWx_jj5LpouMfTTl53HExFZ0AWs8Kiea0RE-q2a4daDwsbZ-D5uSLut2FtZU52HVePa6D4P7u0H_wW2rKbipUP7UNSbHBWiVzIMotMgGbhAdZoILT8SpssogVtJe6utYS2W9XOAjPE1GBQIBfgBrRVnYI2CxspnIojQLpUH8YaRJDQIh3-SSAKRy4LKb7uS9yZmR1L5uLpOGMQkxJgmQstdxI2nXTpX4aJUjCkIo4sD5vBulnuZBF7acEY2iWjUeDxw4bJg3f1WAEAu3zsiBeIGtcwLKqL3YU4ze6szaPA4VKmwHrjoB-PFZf_7B8f9JT2AzqGtpUPRgD9amHzN7iohmas5qcf4GkR34mQ priority: 102 providerName: Springer Nature |
Title | Gremlin-1 associates with fibrillin microfibrils in vivo and regulates mesothelioma cell survival through transcription factor slug |
URI | https://link.springer.com/article/10.1038/oncsis.2013.29 https://www.ncbi.nlm.nih.gov/pubmed/23978876 https://www.proquest.com/docview/1788355151 https://search.proquest.com/docview/1790961032 https://pubmed.ncbi.nlm.nih.gov/PMC3759128 |
Volume | 2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fa9swED_aDsZexrp_ddcFDQbbixPbkmzpcQstpZBSRgd5M5Isb4bYLnXSL7Av3pNsh2btU8EYhGQk6-50P-lOdwBfqRXSMB2HlioTosZPQkmlDSmVnGtFy8JbTBeX6flvdrHkyz3g410Y77RvdDVtVvW0qf5638qb2sxGP7HZ1WJOMy5xXZ3twz4y6IMteh_QO41TzscAjVTM2sZ0lQvNHdNp4sKEJqiEUbjSXV30CGA-9pP8z1jqddDZG3g9gEfyox_kIezZ5i28XAzm8XfwDzf8NeLGMCZqmHbbEXfUSkrn2u_ib5PaueD1xY5g-a66a4lqCnLbp6XHL2rbuYtZq6qtFXFH-6Tb4JKCTEmGvD5k7XTcuOKQPmsP6VabP-_h-uz0en4eDlkWQsNkvA61LlEwrRRlknKL5KEaUWPBKItYZqSVGjGUikysMiWkjUqGD4uU22wgQKAf4KBpG3sEJJO2YEVqCi404hIttNEIkGJdCgcsZQDfxunOb_pYGrm3gVOR9zTKHY3yBFuejNTIB5nq8hhphugIIUoAX7bVKA1uHlRj241rI10Om4gmAXzsibftaqR6ANkOWbcNXKTt3RpkQB9xe2C4AL6PDPBgWE_-wfGzO_kErxKfcsM5GZ7Awfp2Yz8j8FnrCbL7MpvAi5-nl1e_sDRP5xN_iIDvBRMTLwj3lkMNlg |
link.rule.ids | 230,315,730,783,787,867,888,2228,12068,21400,24330,27936,27937,31731,31732,33756,33757,41132,42201,43322,43817,51588,53804,53806,74079,74636 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB7RItFeEI8WUgoYCYle3E1i5-ETQohqgW5Pi7S3yHacdqVu0ja7_QP948wkztKXkHKx4iixx575PDOZD-CzcLmy0kTcCW05WvyYK6EcF0IlidGiKruI6eQkHf-Rv2bJzDvcWp9WOejETlGXjSUf-SjCsxraRjRQXy8uObFGUXTVU2hswFOqw0UMBtksW_tYCB2nSTLUahT5qKltO6cq3ZE47FDlLVv0AGA-zJO8FyztbNDRC3juwSP71kv7JTxx9St4NvHh8ddwgwf-BeJGHjHtp921jFytrKLUfqq_zRaUgtc3W4bt6_l1w3Rdsquelh6fWLiWfsw6nzcLzci1z9oVqhRclMzz-rAl2bhB47CetYe156vTHZge_Zh-H3PPssCtVNGSG1PhxnQqr-I0cSgeYRA1llLIUGZWOWUQQ-nQRjrTuXJhJfGSoabDBgIEsQubdVO7t8Ay5UpZprZMcoO4xOTGGgRIkalyApYqgC_DdBcXfS2NoouBi7zoBVOQYIoYe-4P0ij8nmqLfysggE_r27gbaB507ZoV9VHEYROKOIA3vfDWr4oReqFKTQPI7oh13YEqbd-9U8_PuorbIksUGvIADoYFcOuzHh3B3v9H8BG2xtPJcXH88-T3O9iOO44Nyirch83l1cq9R6SzNB-65fwXxNgCRw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwEB4VKiEuqA9KA7Q1UiW4uJvEzsOnqmq7oqUgDiDtLbIdh67EJkB2-QP9451JnC0vVcrFiqPEnvHMN4_MAHwULldWmog7oS1HjR9zJZTjQqgkMVpUZRcxPT5JD8_lz0ky8flPrU-rHGRiJ6jLxpKPfBShrYa6ERXUqPJpEaffxp-vrjl1kKJIq2-nsQLPM7RSiMOzSbb0txBSTpNkqNso8lFT23ZKFbsj8alDmHf00iOw-Thn8kHgtNNH4xew4YEk-9JT_iU8c_UrWDv2ofLX8AeN_xliSB4x7UngWkZuV1ZRmj_V4mYzSsfrhy3D8e30tmG6LtlN36Ien5i5ln7Supw2M83Izc_aBYoXZFDme_ywOem7QfqwvoMPay8XF5twNv5-9vWQ-44L3EoVzbkxFR5Sp_IqThOHpBIGEWQphQxlZpVTBvGUDm2kM50rF1YSLxlqMjwQLIg3sFo3tXsLLFOulGVqyyQ3iFFMbqxBsBSZKieQqQLYH7a7uOrrahRdPFzkRU-YgghTxDhzd6BG4c9XW_zjhgD2lrfxZNA-6No1C5qjqJ9NKOIAtnriLV8VIwxD8ZoGkN0j63ICVd2-f6ee_u6qb4ssUajUAzgYGODOZz25gu3_r-ADrCEnF79-nBztwHrctdugBMNdWJ3fLNw7BD1z877j5r-jlgaF |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gremlin-1+associates+with+fibrillin+microfibrils+in+vivo+and+regulates+mesothelioma+cell+survival+through+transcription+factor+slug&rft.jtitle=Oncogenesis+%28New+York%2C+NY%29&rft.au=Tamminen%2C+J+A&rft.au=Parviainen%2C+V&rft.au=Ronty%2C+M&rft.au=Wohl%2C+A+P&rft.date=2013-08-01&rft.issn=2157-9024&rft.eissn=2157-9024&rft.volume=2&rft.spage=e66&rft.epage=e66&rft_id=info:doi/10.1038%2Foncsis.2013.29&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2157-9024&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2157-9024&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2157-9024&client=summon |